Skip to main content
SpringerLink
Log in

Infections in neutropenic patients II: Management

  • Review
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Improvement in supportive care including the introduction of new antibiotics, antiviral and antitfungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infection during neutropenia is still a major complication and a great concern for the clinician responsible for the patient. Management of infectious complications in the neutropenic patient is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Frei, E. and Canellos, G.P. (1980) Dose: A critical factor in cancer chemotherapy.Am. J. Med. 69, 585–94.

    Article  PubMed  Google Scholar 

  2. Clift, R.A., Sanders, J.E., Thomas, E.D., Williams, B. and Buckner, CD. (1978) Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplantation.N. Engl. J. Med. 298, 1052–7.

    PubMed  CAS  Google Scholar 

  3. Gomez-Villagran, J.L., Torres-Gomez, A., Gomez-Garcia, P., Martinez-Guibelaide, F. and Valesco-jimena, F. (1984) A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia.Cancer 54, 734–8

    Article  PubMed  CAS  Google Scholar 

  4. Schiffer, CA., Aisner, J., Daly, P.A., Schimpff, S.C and Wiernik, P.H. (1979) Alloimmunization following prophylactic granulocyte transfusion.Blood 54, 766–74.

    PubMed  CAS  Google Scholar 

  5. Strauss, R.G., Connett, J.E., Gale, R.P., Bloomfield, CD., Herzig, G.P., McCullough, J., Maguire, L.C, Winston, D.J., Ho, W., Stump, D.C., Miller, W.V. and Koepke, J.A. (1981) A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia.N. Engl. J, Med. 305, 597–603.

    CAS  Google Scholar 

  6. Gorin, N.C., Dicke, K. and Löwenberg, B. (1993) High dose therapy for acute myelocytic leukemia treatment strategy: What is the choice?Ann. Oncol. 4, 59–80.

    PubMed  Google Scholar 

  7. Dicke, K.A., Hoelzer, D.F., Gorin, N.C, Lowenberg, B. and Gale, R.P. (1993) The role of bone marrow transplantation in adult acute lymphocytic leukemiaAnn. Oncol. 4, 81–90.

    PubMed  Google Scholar 

  8. Shea, T.C, Manson, J.R., Stornoloo, A.M., Newton, B., Breslin, M., Mullen, M., Ward, D.M., Miller, L., Christian, M. and Taetle, R. (1992) Sequential cycles of high-dose carboplatin administered with recombinant human granu-locyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.J. Clin. Oncol. 10, 464–73.

    PubMed  CAS  Google Scholar 

  9. ASCOad hoc colony-stimulating factor guideline expert panel (1994) American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.J. Clin. Oncol. 12, 2471–508.

    Google Scholar 

  10. Pizzo, P.A., Robichaud, K.J., Westley, R. and Commers, J.A. (1982) Fever in the pediatric and young adult patient with cancer: a prospective study of 1001 episodes.Medicin 61, 153–65.

    CAS  Google Scholar 

  11. EORTC International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. (1991) Vancomycin added to empirical combination antibiotic therapy for fever in granulocytope-nic cancer patients.J. Infect. Dis. 163, 951–8.

    Google Scholar 

  12. Pizzo, P.A., Hathorn, J.W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., Rubin, M., Skeleton, J., Thaler, M. and Wesley, R. (1986) A randomized trial comparing ceftazi-dime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.N. Engl. J. Med. 315, 552–8.

    PubMed  CAS  Google Scholar 

  13. Pizzo, P. (1993) Management of fever in patients with cancer and treatment induced neutropenia.N. Engl. J. Med. 328, 1323–32.

    Article  PubMed  CAS  Google Scholar 

  14. De Pauw, B.E., Deresinski, S.C, Feld, R., Lane-Allman, E.F. and Donnelly, P. (1994) Ceftazidime compared with piperacillin and tobramycin for empiric treatment of fever in neutropenic patients with cancer.Ann. Intern. Med. 120, 834–44.

    PubMed  Google Scholar 

  15. Sickles, E.A., Green, W.H. and Wiernik, P.H. (1979) Clinical presentation of infection in granulocytopenic patients.Arch. Intern. Med. 135, 715–9.

    Article  Google Scholar 

  16. Feusner, J., Cohen, R., O’Leary, M. and Beach, B. (1988) Use of chest radiography in the evaluation of fever in neutropenic pediatric oncology patients.J. Clin. Oncol. 6, 1699–702.

    PubMed  CAS  Google Scholar 

  17. Maschmayer, G., Link, H., Hiddemann, W., Meyer, P., Helmerking, M., Eisenmann, E., Schitt, J. and Actam, D. (1994) Pulmonary infiltrations in febrile patients with neutropenia.Cancer 73, 2296–304.

    Article  Google Scholar 

  18. Nováková, I.R.O., Donnelly, J.P. and De Pauw, B. (1993) Potential sites of infection that develop in febrile neutropenic patients.Leukemia Lyrnphoma 10, 461–7.

    Article  Google Scholar 

  19. Barloon, T.J., Galvin, J.R., Mori, M., Stanford, W. and Gingrich, R.D. (1991) High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms.Chest 99, 928–33.

    Article  PubMed  CAS  Google Scholar 

  20. Hughes, W.T., Armstrong, D., Bodey, G.P., Feld, R., Mandell, G.L., Mayers, J.D., Pizzo, P.A., Schimpff, S.C., Shenep, J.L., Wade, J.C, Young, L.S. and Yow, M.D. (1990) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.J. Infect. Dis. 161, 381–96.

    PubMed  CAS  Google Scholar 

  21. Bodey, G.P., Jadeja, L. and Elting, L. (1985)Pseudomonas bacteremia: Retrospective analysis of 410 episodes.Arch. Intern. Med. 145, 1621–9.

    Article  PubMed  CAS  Google Scholar 

  22. Bodey, G.P., Elting, L., Kassamali, H. and Poh Lim, B. (1986)Escherichia coli bacteremia in cancer patients.Am. J, Med. 81, 85–95.

    Article  CAS  Google Scholar 

  23. Schimpff, S., Satterlee, W., Young, V.M. and Serpick, A. (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.N. Engl. J. Med. 284, 1061–5.

    PubMed  CAS  Google Scholar 

  24. The EORTC International Antimicrobial Therapy Project Group. (1987) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.N. Engl J. Med. 317, 1692–8.

    Google Scholar 

  25. Moellering, Jr R.C., Eliopoulos, G.M. and Allan, J.D. (1986) Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.Am. J. Med. 80, 30–4.

    PubMed  Google Scholar 

  26. De Jongh,C.A., Johshi, J.H., Newman, K.A., Moody, M.R., Wharton, R., Standiford, H.C. and Schimpff, S.C. (1986) Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients.Am. J. Med. 80, 96–111.

    Article  PubMed  Google Scholar 

  27. Winston, D.J., Barnes, R.C., Ho, W.G., Young, L.S., Champlin, R.E. and Gale, R.P. (1984) Moxalactam plus piperadllin versus moxalactam plus amikacin in febrile granulocytopenic patients.Am. J. Med. 77, 442–50.

    Article  PubMed  CAS  Google Scholar 

  28. Fainstein, V., Bodey, G.P., Bolivia, R., Elting, L., McCredie, K.B. and Keating, M.J. (1984) Moxalactam plus ticar-cillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.Arch. Intern. Med. 144, 1776–80.

    Article  Google Scholar 

  29. De Jongh,C.A., Joshi, J.H., Thompson, B.W., Newman, K.A., Finley, R.S., Moody, M.R., Salatore, P.C., Tenney, J.H., Drusano, G.L. and Schimpff, S.C. (1986) A double beta-lactam combination versus an aminoglycoside-con-taining regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.Am. J. Med. 80, 101–11.

    PubMed  Google Scholar 

  30. Anaissie, E.J., Fainstein, V., Bodey, G.F., Rolston, K., Elting, L., Kantarjian, H., Cananillas, F. and McCredie, K.B. (1988) Randomized trial of beta-lactam regimens in febrile neutropenic patients.Am. J. Med. 84, 581–9.

    Article  PubMed  CAS  Google Scholar 

  31. Winston, D.J., Winston, G.H., Bruckner, D.A., Gale, R.P. and Champlin, R.E. (1988) Controlled trials of double beta-lactam therapy with cefoperone plus piperacillin in febrile granulocytopenic patients.Am. J. Med. 85, 21–30.

    Article  PubMed  CAS  Google Scholar 

  32. Winston, DJ., Winston, G.H., Bruckner, D.A. and Champlin, R.E. (1991) Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus pipercillin and imipenem alone.Ann. Intern. Med. 115, 849–59.

    PubMed  CAS  Google Scholar 

  33. Sanders, W.E. and Sanders, C.C. (1988) Inducible /Macta-mases: clinical and epidemiologic implications for use of newer cephalosporins.Rev. Infect. Dis. 10, 830–8.

    PubMed  Google Scholar 

  34. Bodey, G.P., Middleman, E., Umsawadi, T. and Rodriguez, V. (1972) Infections in the cancer patient: results with gentamicin sulfate therapy.Cancer 29, 1697–702.

    Article  PubMed  CAS  Google Scholar 

  35. Issell, B.F. and Bodey, G.P. (1980) Mezlocillin for treatment of infections in cancer patients.Antimicrob. Agents. Chemother. 17, 1008–13.

    PubMed  CAS  Google Scholar 

  36. Mortimer, J., Miller, S., Black, D., Kwok, K. and Kirby, W.M. (1988) Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.Am. J. Med. 85, 17–20.

    Article  PubMed  CAS  Google Scholar 

  37. Liang, R., Yung, R., Chiu, E., Chau, P., Chan, T., Lam, W. and Todd, D. (1990) Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.Antimicrob. Agents. Chemother. 34, 1336–41.

    PubMed  CAS  Google Scholar 

  38. Rolston, K.V.I., Berkey, P., Bodey, G.P., Anaissie, E.J., Khardori, N.M., Johi, J.H., Keating, M.J., Holms, F.A., Cabanillas, F.F. and Elting, L. (1992) A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.Arch. Intern. Med. 152, 283–91.

    Article  PubMed  CAS  Google Scholar 

  39. De Pauw,B.E., Kauw, F., Muytjens, H., Williams, K. and Bothof, T. (1983) Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients.J. Antimicrob. Chemother. 12, 93–9.

    Article  PubMed  Google Scholar 

  40. Sanders, J.W., Powe, N.R. and Moor, R.D. (1991) Ceftazidime monotherapy for empiric treatment of neutropenic patients: a metaanalysis.J. Infect. Dis. 164, 907–16.

    PubMed  CAS  Google Scholar 

  41. Samuelson, J., Lönnqvist, B., Palmblad, J., Grimfors, G., Järnmark, M., Lerner, R., Ljungman, P., Nyström-Rosan-der, C. and Öberg, G. (1992) Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy.Scand. J. Infect. Dis. 24, 89–96.

    Article  Google Scholar 

  42. Rubin, M., Hathorn, J.W., Marshall, D., Gress, J., Steinberg, S.M. and Pizzo, P.A. (1988) Gram-positive infections and use of vancomycin in 550 episodes of fever and neurropenia.Ann. Intern. Med. 108, 30–5.

    PubMed  CAS  Google Scholar 

  43. Ramphal, R., Bolger, M., Oblon, D.J., Sherertz,. R.J., Mal-one, J.-D., Rand, K.H., Giliom, M., Shands, Jr. J.W. and Kramer, B.S. (1992) Vancomycin is not essential component of the initial empirical treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.Antimicrob. Agents Chemother. 36, 1062–7.

    PubMed  CAS  Google Scholar 

  44. Engervall, P., Stiernstedt, G., Günther, G. and Björkholm, M. (1992) Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.J. Chemother. 4, 99–106.

    PubMed  CAS  Google Scholar 

  45. Young, L.S. and Hindler, J. (1987) Use of trimethoprim- sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.Rev. Infect. Dis. 9, 177–81.

    Google Scholar 

  46. Stuart, R.K., Braine, H.G., Lietman, P.S., Saral, R. and Fuller, DJ. (1980) Carbenicillin-trimethoprim/sulfa- methoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients: a prospective, randomized, double-blind study.Am. f. Med. 86, 876–85.

    Article  Google Scholar 

  47. Bodey, G.P., Grose, A.W.E. and Keating, M.J. (1982) Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer.Rev. Infect. Dis. 4, 579–85.

    PubMed  CAS  Google Scholar 

  48. Braine, H.G., Stuart, R.K., Saral, R. and Lietman, P.S. (1982) Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.Rev. Infect. Dis. 4, 586–92.

    PubMed  CAS  Google Scholar 

  49. Talcott, J.A., Finberg, R., Mayer, R.J. and Goldman, L. (1988) The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation.Arch. Intern. Med. 148, 2561–8.

    Article  PubMed  CAS  Google Scholar 

  50. Gardembas-Pain, M., Desablens, B., Sensebe, L., Lamy, T., Ghandour, C. and Boasson, M. (1991) Home treatment of febrile neutropenia: An empirical oral antibiotic regimen.Ann. Oncol. 2, 485–7.

    PubMed  CAS  Google Scholar 

  51. Rubinstein, E.B., Rolston, K., Benjamin, R.S., Loewy, J., Escalante, C, Manzullo, E., Hughes, P., Moreland, B., Fender, A., Kennedy, K., Holms, F., Elting, L. and Bodey, G.P. (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.Cancer 71, 3640–6.

    Article  Google Scholar 

  52. The International Antimicrobial Therapy Cooperative Group of the EORTC. (1993) Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infections in patients with cancer and granulocytopenia.Ann. Intern. Med. 119, 584–93.

    Google Scholar 

  53. Gilbert, C, Meisenberg, B., Vredenburgh, J., Ross, M., Hussein, A., Perfect, J. and Peters, W.P. (1994) Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.J. Clin. Oncol. 12, 1005–11.

    PubMed  CAS  Google Scholar 

  54. Maher, D.W., Lieschke, G.J., Green, M., Bischop, J., Stuart-Harris, R., Wolf, ML, Sheridan, W.P., Kefford, R.F., Cebon, J., Olver, I., McKendrick, J., Toner, G., Bradstock, K., Lieschke, M., Cruickshank, S., Tomita, D.K., Hoffman, E.W., Fox, R.M. and Morstyn, G. (1994) Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.Ann. intern. Med. 121, 492–501.

    PubMed  CAS  Google Scholar 

  55. Strauss, R.G. (1993) Therapeutic granulocyte transfusions in 1993.Blood 81, 1675–8.

    PubMed  CAS  Google Scholar 

  56. Caspar, C.B., Seger, R.A., Burger, J. and Gmür, J. (1993) Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor.Blood 81, 2866–71.

    PubMed  CAS  Google Scholar 

  57. Bensinger, W.I., Price, T.H., Dale, D.C., Appelbaum, F.R., Clift, R., Lilleby, K., Williams, B., Storb, R., Thomas, E.D. and Buckner, CD. (1993) The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.Blood 81, 1883–8.

    PubMed  CAS  Google Scholar 

  58. Pizzo, A.P. (1987) After empiric therapy: what to do until the granulocyte comes back.Rev. Infect. Dis. 9, 214–9.

    PubMed  CAS  Google Scholar 

  59. Pizzo, P.A., Robichaud, R.N., Gill, F.A. and Witebsky, F.G. (1982) Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.Am. J. Med. 72, 101–11.

    Article  PubMed  CAS  Google Scholar 

  60. EORTC International Antimicrobial Therapy Cooperative Group. (1989) Empiric antifungal therapy in febrile gran-ulocytopenic patients.Am. J. Med. 86, 668–72.

    Article  Google Scholar 

  61. Commers, J.R., Robichaud, K.J. and Pizzo, P.A. (1984) New pulmonary infiltrates in granulocytopenic cancer patients being treated with antibiotics.Pediatr. Infect. Dis. 3, 423–8.

    Article  PubMed  CAS  Google Scholar 

  62. Canham, E.M., Kennedy, T.C. and Merrick, T.A. (1983) Unexplained pulmonary infiltrates in the compromised patient: an invasive investigation in a consecutive series.Cancer 52, 325–9.

    Article  PubMed  CAS  Google Scholar 

  63. Springmeyer, S.C., Hackman, R.C., Holle, R., Greenberg, G.M., Weems, C.E. and Myerson, D. (1986) Use of bronch-oalveolar lavage to diagnose acute diffuse pneumonia in the immunocompromised host.J. Infect. Dis. 154, 604–10.

    PubMed  CAS  Google Scholar 

  64. Saito, H., Anaissie, E.J., Morice, R.C., Dekmezian, R. and Bodey, G.P. (1988) Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia.Chest 94, 745–9.

    Article  PubMed  CAS  Google Scholar 

  65. Gallas, H.A., Drew, R.H. and Pickard, W.W. (1990) Am-photericin B: 30 years of clinical experience.Rev. Infect. Dis. 12, 308–29.

    Google Scholar 

  66. Powderly, W.G., Kobayashi, G.S., Hertzig, G.P. and Med-off, G. (1988) Amphotericin B-resistant yeast infection in severely immunocompromised patients.Am. J. Med. 84, 826–32.

    Article  PubMed  CAS  Google Scholar 

  67. Meunier, F., Prentice, H.G. and Ringden, O. (1991) Lipo-somal amphotericin B (Ambisome): safety data from a phase II/III clinical trial.J. Antimicrob. Chemother. 28, 83–91.

    PubMed  Google Scholar 

  68. Björkholm, M., Kallberg, N., Grimfors, G., Eklund, L.H., Eksborg, S., Juneskans, O.T. and Udén, A.-M. (1991) Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation. A case report.J. Intern. Med. 230, 173–7.

    Article  PubMed  Google Scholar 

  69. Mills, W., Chopra, R., Linch, D.C. and Goldstone, A.H. (1994) Liposomal amphotericin B in the treatment of fungal infections in neurropenic patients: a single-centre experience of 133 episodes in 166 patients. Br.J. Haematol. 86, 754–60.

    Article  CAS  Google Scholar 

  70. Lopez-Berestein, G., Bodey, G.P., Frankel, L.S. and Mehta, K. (1987) Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.J. Clin. Oncol. 5, 310–7.

    PubMed  CAS  Google Scholar 

  71. van ’t Wout,J.W., Novakova, I., Verhagen, C.A.H., Fibbe, W.E., de Pauw, B.E. and van derMeer,J.W.M. (1991) The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.J. Infect. 22, 45–52.

    Article  Google Scholar 

  72. Pizzo, P.A., Robichaud, K.J., Gill, F.A., Witebsky, F.G., Levine, A.S., Deisseroth, A.B., Glaubiger, D.L., Maclowry, J.D., Magrath, LT., Poplack, D.G. and Simon, R.M. (1979) Duration of empiric antibiotic therapy in granulocytopenic patients with cancer.Am. J. Med. 67, 194–200.

    Article  PubMed  CAS  Google Scholar 

  73. Dinubile, M.J. (1988) Stopping antibiotic therapy in neutropenic patients.Ann. Intern. Med. 108, 289–92.

    PubMed  CAS  Google Scholar 

  74. Joshi, J.H., Schimpff, S.C., Tenney, J.H., Newman, K.A. and De Jongh,C.A. (1984) Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?Am. J. Med. 76, 450–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Hematology and Immunology, Department of Medicine, Karolinska Hospital, S-17176, Stockholm, Sweden

    Per Engervall & Magnus Björkholm

Authors
  1. Per Engervall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magnus Björkholm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Engervall, P., Björkholm, M. Infections in neutropenic patients II: Management. Med Oncol 13, 63–69 (1996). https://doi.org/10.1007/BF02988841

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02988841

Keywords

Search

Navigation